Product Description: Etokimab (Antibody ANB 020) is a humanized monoclonal antibody that targets IL-33. Etokimab can be used for the research of atopic dermatitis[1].
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]Chen YL, et, al. Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis. Sci Transl Med. 2019 Oct 23;11(515):eaax2945.